- M&A Investment
[Pharma / Healthcare]Pharma/Healthcare: Stem cell banking and treatment
Date : 2020.12.29
Stem cell of the companion animal : The company is conducting a cell storage program in which stem cells and immune cells are collected from companion animals and used for their treatment after incubation and proliferation. The program aims to study the stem cells of companion animals in order to provide them with suitable therapy, and store cells for future uses such as curing or treating the intractable diseases of various companion animals. • Veterinary medicine market : The number of companion dogs is increasing continuously in line with an increase in the number of one person households and elderly households, resulting in parallel growth of the veterinary medicine market. According to Research Nester, the global veterinary medicine market for pet animals was USD 16.2 billion in 2018 and is expected to grow to USD 21.2 billion in 2025, at an annual average growth rate of 3.9%. • Patella dislocation, osteoarthrosis, and atopy of dogs: More than 70% of dogs experience patella dislocation, osteoarthrosis, and atopy. As therapy for these diseases, various surgery, steroid, and rehabilitation programs are currently under development. However, dogs are too small to withstand the side effects of reoperation and steroids, and rehabilitation programs cannot be a fundamental means of treatment. However, the stem cells have proven their ability for cartilage and bone regenerative power and the ability to remove atopy-related inflammation of stem cells has been proven. Stempoint Co., Ltd. has the relevant cases.
- Amount : 1M
- Region :